Pacira | PCRX - Market Capitalization


Pacira reported $961.6M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Astellas Pharma JPY 4.33T 546.23B Feb/2026
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
Novo Nordisk A/S DKK 1.54T 86.62B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Supernus Pharmaceuticals USD 3B 1.24B Sep/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026
Zoetis USD 64.85B 4.58B Sep/2025